| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,0 M € | |||||||||||||||||||
| Gross margin | 166,7 k € | -31.7% | 244,0 k € | -35.5% | 378,1 k € | +1728.3% | 20,7 k € | -95.2% | 435,0 k € | +100.2% | 217,3 k € | +51.2% | 143,8 k € | -13.8% | 166,8 k € | +361.7% | 36,1 k € | +143.9% | 14,8 k € | -89.2% | 137,6 k € | +324.9% | 32,4 k € | -88.6% | 283,5 k € | +238.5% | 83,7 k € | +130.4% | -275,8 k € | -185.6% | 322,1 k € | -24.8% | 428,2 k € | +637.5% | -79,7 k € | +37.3% | -127,0 k € | |
| EBITDA | 86,9 k € | -64.2% | 243,0 k € | -35.6% | 377,1 k € | +1803.8% | 19,8 k € | -95.4% | 435,0 k € | +100.2% | 217,3 k € | +52.1% | 142,9 k € | -13.9% | 165,9 k € | +370.7% | 35,3 k € | +650.2% | 4,7 k € | -96.3% | 127,9 k € | +1527.4% | -9,0 k € | -103.8% | 233,7 k € | +409.8% | 45,8 k € | +111.8% | -388,3 k € | -241.2% | 274,9 k € | -16.0% | 327,2 k € | +296.5% | -166,5 k € | +51.2% | -341,4 k € | |
| Operating profit | -92,0 k € | -284.1% | 49,9 k € | -75.0% | 199,8 k € | +281.2% | -110,3 k € | -133.1% | 333,1 k € | +249.5% | 95,3 k € | +845.7% | 10,1 k € | -70.9% | 34,6 k € | +136.0% | -96,1 k € | +41.9% | -165,2 k € | -708.6% | -20,4 k € | +84.7% | -133,8 k € | -159.0% | 226,9 k € | +478.9% | 39,2 k € | +109.8% | -401,5 k € | -486.7% | 103,8 k € | +81.3% | 57,3 k € | +130.0% | -190,8 k € | +60.0% | -476,9 k € | |
| Profit/loss | -99,1 k € | -388.6% | 34,3 k € | -82.0% | 191,0 k € | +261.0% | -118,7 k € | -136.5% | 325,1 k € | +261.0% | 90,0 k € | +1487.1% | 5,7 k € | -81.5% | 30,7 k € | +131.2% | -98,5 k € | +40.3% | -164,9 k € | -949.1% | -15,7 k € | +92.2% | -202,1 k € | -224.5% | 162,4 k € | +541.3% | -36,8 k € | +75.9% | -152,5 k € | -632.6% | 28,6 k € | -47.8% | 54,8 k € | +111.7% | -469,9 k € | +3.4% | -486,4 k € | |
| Equity | 1,1 M € | -8.4% | 1,2 M € | -6.4% | 1,3 M € | -0.7% | 1,3 M € | -8.6% | 1,4 M € | +1.8% | 1,4 M € | +0.0% | 1,4 M € | +0.4% | 1,4 M € | +0.1% | 1,4 M € | -6.8% | 1,5 M € | -10.2% | 1,6 M € | -1.0% | 1,6 M € | +359.2% | -630,4 k € | +20.5% | -792,8 k € | -4.9% | -756,0 k € | -25.3% | -603,5 k € | +4.5% | -632,1 k € | +8.0% | -687,2 k € | -11.3% | -617,4 k € | |
| Total assets | 1,4 M € | -0.8% | 1,4 M € | -20.4% | 1,7 M € | +12.4% | 1,6 M € | -15.5% | 1,8 M € | +25.5% | 1,5 M € | +5.3% | 1,4 M € | -4.6% | 1,5 M € | +1.0% | 1,4 M € | -15.3% | 1,7 M € | -5.2% | 1,8 M € | -2.0% | 1,8 M € | -10.0% | 2,0 M € | +9.4% | 1,9 M € | +10.8% | 1,7 M € | -10.4% | 1,9 M € | -57.6% | 4,4 M € | +1028.6% | 391,9 k € | -35.1% | 603,6 k € | |
| Cash | 581,9 k € | +65.6% | 351,3 k € | +36.8% | 256,8 k € | -38.5% | 417,4 k € | -41.1% | 708,9 k € | +63.5% | 433,7 k € | +128.9% | 189,5 k € | +465.8% | 33,5 k € | -35.2% | 51,7 k € | -68.3% | 163,0 k € | +31.2% | 124,2 k € | -16.8% | 149,2 k € | -29.6% | 211,9 k € | +484.1% | 36,3 k € | +163.3% | 13,8 k € | -37.4% | 22,0 k € | -77.5% | 98,0 k € | +3644.6% | 2,6 k € | -75.6% | 10,7 k € | |
| Debts | 294,9 k € | +40.4% | 210,1 k € | -56.6% | 484,5 k € | +71.5% | 282,5 k € | -37.1% | 449,1 k € | +345.2% | 100,9 k € | +271.3% | 27,2 k € | -72.9% | 100,3 k € | +16.1% | 86,4 k € | -65.3% | 248,6 k € | +41.1% | 176,2 k € | -10.6% | 197,1 k € | -92.6% | 2,7 M € | +0.5% | 2,7 M € | +8.9% | 2,4 M € | -1.7% | 2,5 M € | -51.0% | 5,1 M € | +368.5% | 1,1 M € | -11.6% | 1,2 M € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | 0,8 | 1 | 1 | 1 | 1 | 1,1 | 1,7 | 3,1 | |||||||||||||||||||
Public limited company · Seneffe · incorporated on 07/03/2000
Public limited company loss-making in the latest fiscal year. Cash position rising (+65.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
LIFESTREAM PHARMA is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Seneffe.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette